European Archives - Page 274 of 1124 - European Medical Journal

COVID-19 Vaccine Cuts Childhood Asthma Symptoms

A RECENT study revealed a significant association between COVID-19 vaccination rates and decreased symptomatic asthma among children.

Childhood Air Pollution Exposure Linked to Adult Bronchitis Symptoms

A recent study revealed that long-term exposure to air pollution during childhood can lead to bronchitis symptoms in adulthood.

New Insights into Neutrophils’ Role in CAR-T Therapy Complications

Recent research suggests that neutrophils may play a crucial role in cytokine release syndrome, a severe and life-threatening side effect of CAR-T therapy.

Indigenous Children Show Better Antibiotic Response in Paediatric Bronchiectasis

A study shows that Indigenous children with bronchiectasis and low cough scores have higher odds of symptom resolution following a 14-day antibiotic treatment for non-severe exacerbations.

Black Women Face Higher Early Death Rates from Gynaecologic Cancers

Emerging research from the University of South Carolina has revealed racial and ethnic differences in early death after cancer diagnosis.

Potential of JAK Inhibitors with Immunotherapy as Cancer Treatment

New research shows the role of JAK inhibitors in boosting immune responses against cancer.

Intermittent Fasting Diet Shows Promise for Diabetes Management

A recent study suggests that 5:2 intermittent fasting meal replacement diet could be an effective initial lifestyle intervention for managing early type 2 diabetes.

Semaglutide Tied to Increased Risk of Serious Eye Disease

New research indicates a potential link between semaglutide, a GLP-1 receptor agonist, and a higher risk of NAION in type 2 diabetes and overweight patients.

EASL 2024 Symposium: Shining a Light on Unexplained Cholestasis

Adverse event reporting: ▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety…

Researchers Identify Biomarker for Recurrence in Renal Cell Carcinoma

A new study has developed and validated a 15-gene expression-based biomarker that could facilitate risk stratification for clear cell renal cell carcinoma.